ROGSX
Price
$66.35
Change
+$0.38 (+0.58%)
Updated
Jun 2 closing price
Net Assets
847.54M
VITAX
Price
$515.18
Change
+$6.47 (+1.27%)
Updated
Jun 2 closing price
Net Assets
146.53B
Interact to see
Advertisement

ROGSX vs VITAX

Header iconROGSX vs VITAX Comparison
Open Charts ROGSX vs VITAXBanner chart's image
ROGSX vs VITAX Comparison Chart in %
View a ticker or compare two or three
VS
ROGSX vs. VITAX commentary
Jun 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ROGSX is a Buy and VITAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITAX has more cash in the bank: 147B vs. ROGSX (848M). VITAX pays higher dividends than ROGSX: VITAX (0.32) vs ROGSX (0.03). ROGSX was incepted earlier than VITAX: ROGSX (27 years) vs VITAX (22 years). ROGSX (0.90) is less costly to investors than VITAX (0.09). VITAX is a more actively managed with annual turnover of: 8.00 vs. ROGSX (4.00). ROGSX has a lower initial minimum investment than VITAX: ROGSX (2000) vs VITAX (100000). VITAX annual gain was more profitable for investors over the last year : 62.42 vs. ROGSX (39.46). VITAX return over 5 years is better than : 169.74 vs. ROGSX (62.90).
ROGSXVITAXROGSX / VITAX
Total Expense Ratio0.900.091,000%
Annual Report Gross Expense Ratio0.900.091,000%
Fund Existence27 years22 years-
Gain YTD20.69231.84165%
Front LoadN/AN/A-
Min. Initial Investment20001000002%
Min. Initial Investment IRAN/AN/A-
Net Assets848M147B1%
Annual Yield % from dividends0.030.328%
Returns for 1 year39.4662.4263%
Returns for 3 years89.09134.5666%
Returns for 5 years62.90169.7437%
Returns for 10 years291.16808.1436%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DILCX16.280.26
+1.62%
Davis International C
CSFCX57.30N/A
N/A
Cohen & Steers Global Realty C
OGLYX96.57N/A
N/A
Invesco Global Y
MXETX14.47N/A
N/A
Empower Core Strategies US Eq Inv
LYFCX15.83N/A
N/A
AlphaCentric Life Sciences & Hlthcare C